Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation

Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation

Bibliographic Details
Main Authors: Y Chen, P Jobanputra, P Barton, S Bryan, A Fry-Smith, G Harris, R Taylor
Format: Article
Language:English
Published: NIHR Journals Library 2008-04-01
Series:Health Technology Assessment
Online Access:https://doi.org/10.3310/hta12110
id doaj-a005146703fe405a965ba87c5a4bd9b4
record_format Article
spelling doaj-a005146703fe405a965ba87c5a4bd9b42020-11-24T20:45:30ZengNIHR Journals LibraryHealth Technology Assessment1366-52782008-04-01121110.3310/hta12110Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluationY Chen0P JobanputraP BartonS BryanA Fry-SmithG HarrisR TaylorDepartment of Public Health and Epidemiology, University of Birmingham, UKhttps://doi.org/10.3310/hta12110
collection DOAJ
language English
format Article
sources DOAJ
author Y Chen
P Jobanputra
P Barton
S Bryan
A Fry-Smith
G Harris
R Taylor
spellingShingle Y Chen
P Jobanputra
P Barton
S Bryan
A Fry-Smith
G Harris
R Taylor
Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation
Health Technology Assessment
author_facet Y Chen
P Jobanputra
P Barton
S Bryan
A Fry-Smith
G Harris
R Taylor
author_sort Y Chen
title Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation
title_short Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation
title_full Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation
title_fullStr Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation
title_full_unstemmed Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation
title_sort cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation
publisher NIHR Journals Library
series Health Technology Assessment
issn 1366-5278
publishDate 2008-04-01
url https://doi.org/10.3310/hta12110
work_keys_str_mv AT ychen cyclooxygenase2selectivenonsteroidalantiinflammatorydrugsetodolacmeloxicamcelecoxibrofecoxibetoricoxibvaldecoxibandlumiracoxibforosteoarthritisandrheumatoidarthritisasystematicreviewandeconomicevaluation
AT pjobanputra cyclooxygenase2selectivenonsteroidalantiinflammatorydrugsetodolacmeloxicamcelecoxibrofecoxibetoricoxibvaldecoxibandlumiracoxibforosteoarthritisandrheumatoidarthritisasystematicreviewandeconomicevaluation
AT pbarton cyclooxygenase2selectivenonsteroidalantiinflammatorydrugsetodolacmeloxicamcelecoxibrofecoxibetoricoxibvaldecoxibandlumiracoxibforosteoarthritisandrheumatoidarthritisasystematicreviewandeconomicevaluation
AT sbryan cyclooxygenase2selectivenonsteroidalantiinflammatorydrugsetodolacmeloxicamcelecoxibrofecoxibetoricoxibvaldecoxibandlumiracoxibforosteoarthritisandrheumatoidarthritisasystematicreviewandeconomicevaluation
AT afrysmith cyclooxygenase2selectivenonsteroidalantiinflammatorydrugsetodolacmeloxicamcelecoxibrofecoxibetoricoxibvaldecoxibandlumiracoxibforosteoarthritisandrheumatoidarthritisasystematicreviewandeconomicevaluation
AT gharris cyclooxygenase2selectivenonsteroidalantiinflammatorydrugsetodolacmeloxicamcelecoxibrofecoxibetoricoxibvaldecoxibandlumiracoxibforosteoarthritisandrheumatoidarthritisasystematicreviewandeconomicevaluation
AT rtaylor cyclooxygenase2selectivenonsteroidalantiinflammatorydrugsetodolacmeloxicamcelecoxibrofecoxibetoricoxibvaldecoxibandlumiracoxibforosteoarthritisandrheumatoidarthritisasystematicreviewandeconomicevaluation
_version_ 1716814565034950656

Similar Items